Adverse effects of antipsychotic medications.
Am Fam Physician. 2010.
PMID: 20187598
Review.
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1953 | 1 |
| 1955 | 1 |
| 1956 | 4 |
| 1957 | 3 |
| 1958 | 8 |
| 1959 | 1 |
| 1960 | 3 |
| 1961 | 2 |
| 1962 | 4 |
| 1963 | 1 |
| 1964 | 5 |
| 1965 | 8 |
| 1966 | 24 |
| 1967 | 18 |
| 1968 | 33 |
| 1969 | 36 |
| 1970 | 39 |
| 1971 | 45 |
| 1972 | 55 |
| 1973 | 70 |
| 1974 | 76 |
| 1975 | 77 |
| 1976 | 67 |
| 1977 | 51 |
| 1978 | 66 |
| 1979 | 59 |
| 1980 | 58 |
| 1981 | 70 |
| 1982 | 69 |
| 1983 | 53 |
| 1984 | 61 |
| 1985 | 87 |
| 1986 | 77 |
| 1987 | 86 |
| 1988 | 115 |
| 1989 | 126 |
| 1990 | 148 |
| 1991 | 160 |
| 1992 | 178 |
| 1993 | 186 |
| 1994 | 208 |
| 1995 | 204 |
| 1996 | 206 |
| 1997 | 224 |
| 1998 | 218 |
| 1999 | 245 |
| 2000 | 286 |
| 2001 | 314 |
| 2002 | 338 |
| 2003 | 380 |
| 2004 | 430 |
| 2005 | 461 |
| 2006 | 540 |
| 2007 | 625 |
| 2008 | 621 |
| 2009 | 588 |
| 2010 | 631 |
| 2011 | 655 |
| 2012 | 656 |
| 2013 | 659 |
| 2014 | 664 |
| 2015 | 686 |
| 2016 | 743 |
| 2017 | 772 |
| 2018 | 733 |
| 2019 | 735 |
| 2020 | 743 |
| 2021 | 809 |
| 2022 | 797 |
| 2023 | 683 |
| 2024 | 755 |
| 2025 | 437 |
Search Results
17,413 results
Results by year
Citations
7
articles
found by citation matching
Management of common adverse effects of antipsychotic medications.
World Psychiatry. 2018.
PMID: 30192094
Free PMC article.
Management of serious cardiac adverse effects of antipsychotic medications.
Ment Health Clin. 2018.
PMID: 29955530
Free PMC article.
Search results
Page 1
Adverse effects of antipsychotic medications.
Am Fam Physician. 2010 Mar 1;81(5):617-22.
Am Fam Physician. 2010.
PMID: 20187598
Free article.
Review.
The use of antipsychotic medications entails a difficult trade-off between the benefit of alleviating psychotic symptoms and the risk of troubling, sometimes life-shortening adverse effects. ...Primary care physicians should understand the individual …
The use of antipsychotic medications entails a difficult trade-off between the benefit of alleviating psychotic symptoms and t …
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview.
CNS Drugs. 2021 Jan;35(1):39-59. doi: 10.1007/s40263-020-00779-5. Epub 2021 Jan 28.
CNS Drugs. 2021.
PMID: 33507525
Free PMC article.
Review.
However, all LAI antipsychotics have unique formulations and pharmacokinetic characteristics that have implications for medication selection, administration interval, and injection site. ...Relevant data on drug properties, administration details, pharmacokinetic pa …
However, all LAI antipsychotics have unique formulations and pharmacokinetic characteristics that have implications for medication …
Current Treatment Options and Emerging Agents for Schizophrenia.
J Clin Psychiatry. 2020 Apr 14;81(3):MS19053BR3C. doi: 10.4088/JCP.MS19053BR3C.
J Clin Psychiatry. 2020.
PMID: 32297721
Free article.
Review.
The currently available antipsychotics mostly treat the positive symptoms of schizophrenia and have at least one adverse effect as a potential liability. ...Mechanisms of action that are under investigation include dopamine D3 antagonism/serotonin 5-HT1A partial ago …
The currently available antipsychotics mostly treat the positive symptoms of schizophrenia and have at least one adverse effec …
A safety evaluation of aripiprazole in the treatment of schizophrenia.
Expert Opin Drug Saf. 2020 Dec;19(12):1529-1538. doi: 10.1080/14740338.2020.1832990. Epub 2020 Oct 16.
Expert Opin Drug Saf. 2020.
PMID: 33064050
Review.
INTRODUCTION: Aripiprazole is a third generation antipsychotic approved by the US Food and Drug Administration (FDA) for the treatment of schizophrenia. ...EXPERT OPINION: Aripiprazole is a generally well-tolerated third-generation antipsychotic with low rates of mo …
INTRODUCTION: Aripiprazole is a third generation antipsychotic approved by the US Food and Drug Administration (FDA) for the treatmen …
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence.
J Clin Psychiatry. 2016;77(suppl 3):1-24. doi: 10.4088/JCP.15032su1.
J Clin Psychiatry. 2016.
PMID: 27732772
Free article.
Review.
Long-acting injectable antipsychotics (LAIs) are among the most effective treatments in psychiatry, yet they remain underutilized in clinical practice. ...LAIs vary considerably in their propensity to cause certain adverse effects, including weight gain, meta …
Long-acting injectable antipsychotics (LAIs) are among the most effective treatments in psychiatry, yet they remain underutilized in …
Efficacy, acceptability and side-effects of oral versus long-acting- injectables antipsychotics: Systematic review and network meta-analysis.
Eur Neuropsychopharmacol. 2024 Jun;83:11-18. doi: 10.1016/j.euroneuro.2024.03.003. Epub 2024 Mar 15.
Eur Neuropsychopharmacol. 2024.
PMID: 38490016
Free article.
Long-acting injectable antipsychotics (LAIs) are primarily used for relapse prevention, but in some settings and situations, they may also be useful for acute treatment of schizophrenia. ...LAIs are efficacious for acute schizophrenia and may have some benefits compared to …
Long-acting injectable antipsychotics (LAIs) are primarily used for relapse prevention, but in some settings and situations, they may …
The effects of antipsychotic medications on microbiome and weight gain in children and adolescents.
BMC Med. 2019 Jun 19;17(1):112. doi: 10.1186/s12916-019-1346-1.
BMC Med. 2019.
PMID: 31215494
Free PMC article.
Review.
BACKGROUND: Atypical antipsychotics, also known as second-generation antipsychotics, are commonly prescribed as treatment for psychotic disorders in adults, as well as in children and adolescents with behavioral problems. However, in many cases, second-generation …
BACKGROUND: Atypical antipsychotics, also known as second-generation antipsychotics, are commonly prescribed as treatment for …
Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review.
Br J Psychiatry Suppl. 2009 Nov;52:S13-9. doi: 10.1192/bjp.195.52.s13.
Br J Psychiatry Suppl. 2009.
PMID: 19880912
Review.
AIMS: To review the pharmacology, pharmacokinetics and adverse effect profiles of currently available antipsychotic long-acting injections (LAIs). ...All LAIs offer the prospect of assured adherence (although patients may still default on treatment) but their use is …
AIMS: To review the pharmacology, pharmacokinetics and adverse effect profiles of currently available antipsychotic long-actin …
Debate article: Antipsychotic medications are clinically useful for the treatment of delirium.
Int J Geriatr Psychiatry. 2018 Nov;33(11):1420-1427. doi: 10.1002/gps.4759. Epub 2017 Jul 30.
Int J Geriatr Psychiatry. 2018.
PMID: 28758323
Review.
Prescribing of antipsychotic medications for patients with delirium remains controversial. Concerns exist that these vulnerable and frail patients may be prescribed antipsychotics inappropriately as a substitute for non-pharmacological approaches when identif …
Prescribing of antipsychotic medications for patients with delirium remains controversial. Concerns exist that these vulnerabl …
Disability and Adverse Effects of Oral Versus Long-Acting Injectable Antipsychotics in Schizophrenia-Spectrum and Bipolar Disorder: A Comparison Based on Data-Driven Taxonomy.
Clin Drug Investig. 2024 Sep;44(9):715-727. doi: 10.1007/s40261-024-01391-x. Epub 2024 Sep 20.
Clin Drug Investig. 2024.
PMID: 39302586
Free PMC article.
OBJECTIVES: The aims of this cross-sectional study are to investigate the impact of adverse effects of antipsychotic drugs on patients' daily life functioning, comparing oral and long-acting injectable (LAI) antipsychotics, and further dividing anti …
OBJECTIVES: The aims of this cross-sectional study are to investigate the impact of adverse effects of antipsychotic dr …
Cite